What is the Impact Factor of Personalized Medicine?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Personalized Medicine is 1.20, ranking in quartile Q4 of Web of Science (SCIE).

Is Personalized Medicine indexed in Web of Science or Scopus?

Yes, Personalized Medicine is indexed in Web of Science (SCIE, Q4 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.357 (Q3) and an H-index of 40.

Who publishes Personalized Medicine and what is the Article Processing Charge (APC)?

Personalized Medicine is published by Future Medicine Ltd.. The estimated Article Processing Charge (APC) is approximately $2,849 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Personalized Medicine?

The official ISO-4 abbreviation of Personalized Medicine is "PERS MED". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q4Scopus Q3SCImago #15,403Hybrid

Personalized Medicine

Abbreviation (ISO):PERS MED

•

Identifier (ISSN):1741-0541(Print)/1744-828X(Online)

•

Publisher:Future Medicine Ltd.

Official Website Submission Portal Compare

Clarivate IF (2026)

1.2↓ -0.6

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Personalized Medicine

WoS Q4

Annual Impact Factor Metric

Current (2026):1.2

Scopus SJR & RankScopus Q3

0.357

#15,403

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

40 papers with at least that number of citations each

WoS: SCIE / JCRQ4

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

48articles/year

8.94% Gold OA•77.27% Original Research

Aims & Scope

Personalized Medicine (ISSN 1741-0541) translates recent genomic, genetic and proteomic advances into the clinical context. The journal provides an integrated forum for all players involved - academic and clinical researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organizations and others in the healthcare community. Personalized Medicine assists these parties to shape thefuture of medicine by providing a platform for expert commentary and analysis. The journal addresses scientific, commercial and policy issues in the field of precision medicine and includes news and views, current awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles.

Topics Covered (Recognized by AI)

Medicine96.6%Biology93.8%Genetics83.3%Bioinformatics60.9%Chemistry53.3%Internal medicine52.7%Biochemistry52%Pathology51.1%Gene44.1%Personalized medicine38.6%Computer science34.7%Political science30.6%Law29.6%Psychology26.4%Computational biology25.8%Precision medicine24.7%Economics24.6%Pharmacology21.4%

Primary Research Areas

Medicine Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank307/356

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank283/356

IndexSCIE

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRSCIE	307/356	Q4
PHARMACOLOGY & PHARMACY	JCISCIE	283/356	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF1.2

Articles / Year36

Total Citations4

2025

IF1.8

Articles / Year51

Total Citations81

2024

IF1.7

Articles / Year34

Total Citations66

2023

IF2.3

Articles / Year45

Total Citations210

2022

IF2.119

Articles / Year49

Total Citations368

Year	Impact Factor	Articles / Year	Total Citations
2026	1.2	36	4
2025	1.8	51	81
2024	1.7	34	66
2023	2.3	45	210
2022	2.119	49	368
2021	2.512	60	528
2020	2.318	54	601
2019	1.414	53	532
2018	1.032	82	1,573
2017	—	59	974
2016	—	87	849
2015	—	71	804

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #15,403Scopus Q3SCImago Profile

Scopus Coverage:2006-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q3

0.357

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

1.23

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,849 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations192

3-Year Documents131

Citable Documents126

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate49.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q3

PharmacologyQ3

Molecular MedicineQ4

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Personalized Medicine (abbr: PERS MED, ISSN: 1741-0541) is a peer-reviewed international scholarly journal in the field of Medicine, published by Future Medicine Ltd. in England since 2004. The periodical holds a Journal Impact Factor (JIF) of 1.20, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.357 (Q3), an H-index of 40.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 48 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,849 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.